Zobrazeno 1 - 10
of 10
pro vyhledávání: '"S, Cebolla Lorenzo"'
Autor:
B. Orgaz Álvarez, E. Jiménez Sola, M. Velasco Santos, P. Ibáñez Mendoza, Á. de Vicente Blanco, S. Cebolla Lorenzo
Publikováno v:
European Psychiatry, Vol 67, Pp S428-S429 (2024)
Introduction Lithium is considered the gold standard mood stabiliser for bipolar disorder, yet its use during pregnancy remains controversial, demanding careful consideration of potential risks and benefits. Classically, it has been associated with a
Externí odkaz:
https://doaj.org/article/c01508faa5e64f35b944e029849c6c80
Autor:
J. Andreo Jover, M.P. Vidal-Villegas, R. Mediavilla, I. Louzao Rojas, S. Cebolla Lorenzo, E. Fernández Jiménez, A. Muñoz-Sanjosé, M.F. Bravo-Ortiz, G. Martinez-Ales, C. Bayón-Pérez
Publikováno v:
European Psychiatry, Vol 65, Pp S381-S381 (2022)
Introduction Long-term COVID-19 effects has been recently described as persistent and prolonged symptoms after an acute and severe SARS-COV-2 (1). An important concern is that the sequelae of severe COVID-19 may suppose a substantial outpatient 's bu
Externí odkaz:
https://doaj.org/article/cd862c3e93f448bea2fb2a18a3ceacaf
Autor:
A. Muñoz San José, C. Oreja-Guevara, S. Cebolla Lorenzo, L. Carrillo Notario, B. Rodríguez Vega, C. Bayón Pérez
Publikováno v:
Neurología, Vol 31, Iss 2, Pp 113-120 (2016)
Resumen: La presencia de depresión o ansiedad asociada al diagnóstico de esclerosis múltiple (EM) se ha relacionado con una peor evolución de la enfermedad, con mayor número de brotes, con peor adherencia al tratamiento y una mayor disregulació
Externí odkaz:
https://doaj.org/article/d57b5b34de904af9b8c806f90c6b77c2
Autor:
A. Muñoz San José, C. Oreja-Guevara, S. Cebolla Lorenzo, L. Carrillo Notario, B. Rodríguez Vega, C. Bayón Pérez
Publikováno v:
Neurología (English Edition), Vol 31, Iss 2, Pp 113-120 (2016)
Depression or anxiety in multiple sclerosis (MS) has been linked to a more severe course of the disease and higher numbers of relapses, in addition to poorer treatment adherence and exacerbated immune system dysregulation. Recent investigations indic
Externí odkaz:
https://doaj.org/article/bebc29ae300748489af8919b2fbd6122
Autor:
S. Cebolla Lorenzo, A. Muñoz San José, C. Bayón Pérez, L. Carrillo Notario, Celia Oreja-Guevara, B. Rodríguez Vega
Publikováno v:
Neurología, Vol 31, Iss 2, Pp 113-120 (2016)
Resumen: La presencia de depresión o ansiedad asociada al diagnóstico de esclerosis múltiple (EM) se ha relacionado con una peor evolución de la enfermedad, con mayor número de brotes, con peor adherencia al tratamiento y una mayor disregulació
Autor:
Celia Oreja-Guevara, L. Carrillo Notario, S. Cebolla Lorenzo, B. Rodríguez Vega, C. Bayón Pérez, A. Muñoz San José
Publikováno v:
Neurología (English Edition), Vol 31, Iss 2, Pp 113-120 (2016)
Depression or anxiety in multiple sclerosis (MS) has been linked to a more severe course of the disease and higher numbers of relapses, in addition to poorer treatment adherence and exacerbated immune system dysregulation. Recent investigations indic
Autor:
A, Muñoz San José, C, Oreja-Guevara, S, Cebolla Lorenzo, L, Carrillo Notario, B, Rodríguez Vega, C, Bayón Pérez
Publikováno v:
Neurologia (Barcelona, Spain). 31(2)
Depression or anxiety in multiple sclerosis (MS) has been linked to a more severe course of the disease and higher numbers of relapses, in addition to poorer treatment adherence and exacerbated immune system dysregulation. Recent investigations indic
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Mediavilla R; Department of Psychiatry, Universidad Autónoma de Madrid (UAM), Madrid, Spain.; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain., Martínez-Alés G; Department of Epidemiology, Columbia University Mailman School of Public Health, New York, NY, United States.; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain.; Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.; CAUSALab, Harvard T.H. Chan School of Public Health, Boston, MA, USA., Andreo-Jover J; Department of Psychiatry, Universidad Autónoma de Madrid (UAM), Madrid, Spain.; Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain., Louzao-Rojas I; Department of Psychiatry, Clinical Psychology and Mental Health, La Paz University Hospital, Madrid, Spain., Cebolla-Lorenzo S; Department of Psychiatry, Clinical Psychology and Mental Health, La Paz University Hospital, Madrid, Spain., Muñoz-San-José A; Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.; Department of Psychiatry, Clinical Psychology and Mental Health, La Paz University Hospital, Madrid, Spain., Fernández-Jiménez E; Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.; Department of Psychiatry, Clinical Psychology and Mental Health, La Paz University Hospital, Madrid, Spain., Aguirre P; Department of Psychiatry, Clinical Psychology and Mental Health, La Paz University Hospital, Madrid, Spain., Luis Ayuso-Mateos J; Department of Psychiatry, Universidad Autónoma de Madrid (UAM), Madrid, Spain.; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain.; Department of Psychiatry, La Princesa University Hospital, Instituto de Investigación Sanitaria Princesa (IIS-Princesa), Madrid, Spain., Bravo-Ortiz MF; Department of Psychiatry, Universidad Autónoma de Madrid (UAM), Madrid, Spain.; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain.; Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.; Department of Psychiatry, Clinical Psychology and Mental Health, La Paz University Hospital, Madrid, Spain., Bayón-Pérez C; Department of Psychiatry, Universidad Autónoma de Madrid (UAM), Madrid, Spain.; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain.; Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.; Department of Psychiatry, Clinical Psychology and Mental Health, La Paz University Hospital, Madrid, Spain.
Publikováno v:
Revista de psiquiatria y salud mental [Rev Psiquiatr Salud Ment] 2022 Oct 07. Date of Electronic Publication: 2022 Oct 07.